Polaris Capital Management, LLC Abb Vie Inc. Transaction History

Polaris Capital Management, LLC

$1.83 Billion
Q3 2024

A detailed history of Polaris Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Polaris Capital Management, LLC holds 235,379 shares of ABBV stock, worth $41.3 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares

235,379

Previous 234,479 0.38%

Holding current value

$41.3 Million

Previous $40.2 Million 15.58%

% of portfolio

2.54%

Previous 2.41%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $147,456 - $179,397	900 Added 0.38%	235,379 $46.5 Million
Q2 2024 Jul 26, 2024	SELL	$154.79 - $180.76 $588,202 - $686,888	-3,800 Reduced 1.59%	234,479 $40.2 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $9.24 Million - $10.5 Million	-57,800 Reduced 19.52%	238,279 $43.4 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $1.09 Million - $1.22 Million	-7,900 Reduced 2.6%	296,079 $45.9 Million
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $15.4 Million - $17.8 Million	-115,037 Reduced 27.45%	303,979 $45.3 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $204,330 - $254,275	-1,542 Reduced 0.37%	419,016 $56.5 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $138,310 - $165,870	-1,000 Reduced 0.24%	420,558 $68 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.01 Million - $1.16 Million	-7,557 Reduced 1.76%	421,558 $56.6 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $4.45 Million - $5.65 Million	-32,300 Reduced 7.0%	429,115 $65.7 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $3.04 Million - $3.77 Million	-23,000 Reduced 4.75%	461,415 $74.8 Million
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $75,201 - $95,151	-700 Reduced 0.14%	484,415 $65.6 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $6.42 Million - $7.28 Million	60,300 Added 14.19%	485,115 $52.3 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $536,571 - $597,771	5,100 Added 1.22%	424,815 $47.9 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $3.13 Million - $3.45 Million	-30,600 Reduced 6.8%	419,715 $48.8 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $29 Million - $39.1 Million	359,700 Added 396.95%	450,315 $48.3 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $27,147 - $31,862	-316 Reduced 0.35%	90,615 $7.94 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $6.67 Million - $8.93 Million	90,931 New	90,931 $8.93 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Capital Management, LLC with notifications on news.

Account

Polaris Capital Management, LLC Abb Vie Inc. Transaction History